Roche descendant André Hoffmann on pharma, feuds and family business 

André Hoffmann sits more than 400 places below Elon Musk in Bloomberg’s Billionaires Index. His net worth is estimated at just under $7 billion (CHF7.7 billion), against the $450 billion attributed to the world’s richest man. If anything, the gap understates the gulf between the soft-spoken, beetle-browed Hoffmann, who is the great-grandson of Fritz Hoffmann-La Roche, founder of pharmaceuticals group Roche, and the noisy SpaceX creator and X owner. “The arrogance of these guys knows no limit,” grumbles the 66-year-old Hoffmann about Musk and his assumption, shared by many of his fellow Silicon Valley entrepreneurs, that he knows how to change the world single-handedly. Hoffmann has been vice-chair of Roche since 2006 and a board director since 1996. Among many other roles, he is a trustee of the World Economic Forum, whose annual summit takes place in Davos this week, and co-founder of InTent, a platform for developing sustainable solutions to societal problems. Hoffmann advocates ...